Trial Profile
Pharmacokinetic study of lenvatinib suspension by a simple suspension method in thyroid cancer patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2019
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Pharmacokinetics
- 08 Oct 2018 New trial record